当前位置: 首页 >> 检索结果
共有 62501 条符合本次的查询结果, 用时 3.3505988 秒

261. Hemodynamic Super-Responders in Pulmonary Embolism: Optimism and Uncertainty.

作者: Kevin G Buda.;Samuel Horr.;Ann Gage.
来源: Circ Cardiovasc Interv. 2025年18卷10期e015962页

262. Guidance for Incorporating FDA Processes into the ACC/AHA Clinical Practice Guideline Methodology: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

作者: .;Hani Jneid.;Abdul R Abdullah.;Victor A Ferrari.;Richard J Kovacs.;Debabrata Mukherjee.;Daichi Shimbo.
来源: Circulation. 2025年152卷18期e323-e331页

263. 2025 ACC/AHA Clinical Practice Guidelines Core Principles and Development Process: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

作者: .;Catherine M Otto.;Abdul R Abdullah.;Leslie L Davis.;Victor A Ferrari.;Stephen Fremes.;Debabrata Mukherjee.;Lauren Prestera.;Boback Ziaeian.
来源: Circulation. 2025年152卷18期e359-e370页

264. 2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

作者: .;Dhruv S Kazi.;Abdul R Abdullah.;Suzanne V Arnold.;Anirban Basu.;Brandon K Bellows.;Khadijah Breathett.;Derek S Chew.;David J Cohen.;Colette DeJong.;Paul A Heidenreich.;Susan Hennessy.;Inmaculada Hernandez.;Nicolas Isaza.;Karen E Joynt Maddox.;Ann Marie Navar.;Ankur Pandya.;Kendra D Sims.;Merilyn S Varghese.;Liesl Zühlke.
来源: Circulation. 2025年152卷18期e332-e358页
The "2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement)" describes a systematic approach for consistent implementation of "economic value statements" across ACC/AHA guidelines. It updates the cost-effectiveness threshold and proposes a new level of certainty framework that summarizes the strength of the available evidence. Additionally, it describes how cost-effectiveness analyses (CEAs) can help advance equity in population cardiovascular health.

265. Vagal Influence on Atrial Electrograms: Differentiating Functional and Structural Fragmentation in Ganglionated Plexi Regions.

作者: Andrea Giomi.;Andrea Bernardini.;Alessandro Paoletti Perini.;Margherita Padeletti.;Cristiano Salvatore Zaccaria.;Davide Ciliberti.;Federica Michelotti.;Umberto Signorini.;Massimo Milli.
来源: Circ Arrhythm Electrophysiol. 2025年18卷10期e014122页

266. Comparison of Extrastimulus Pacing Strategies for the Detection of Arrhythmogenic Substrate for Ventricular Tachycardia: Insights From a Porcine Ischemia-Reperfusion Injury Model.

作者: Ashwin Bhaskaran.;Tejas Deshmukh.;Dinesh Selvakumar.;Richard Bennett.;Samual Turnbull.;Timothy G Campbell.;Yasuhito Kotake.;Michael A Barry.;Juntang Lu.;Lachlan Pearson.;Eddy Kizana.;James J H Chong.;Saurabh Kumar.
来源: Circ Arrhythm Electrophysiol. 2025年18卷10期e013902页
Multiple extrastimulus (ES) pacing protocols exist for ventricular substrate mapping. Despite being increasingly adopted in clinical practice, direct protocol comparisons have been limited. This study aims to compare the substrate delineation and mapping efficiency of right ventricular pacing+ES (RVp+ES) and sensed ES pacing strategies in a large animal ischemia-reperfusion injury model.

267. Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.

作者: Francesco Gentile.;Eliana Carapellucci.;Vincenzo Uggenti.;Valentina Lorenzoni.;Francesco Arsì.;Giulia Fulceri.;Michele Coceani.;Angelo Monteleone.;Dante Chiappino.;Claudio Passino.;Alberto Giannoni.;Sergio Berti.;Michele Emdin.;Alberto Clemente.
来源: Circulation. 2025年
The clinical significance and outcome predictors of anomalous aortic origin of a coronary artery (AAOCA) in adults remains unclear. Therefore, the aim of this study was to analyze the clinical and prognostic implications of AAOCA in a large cohort of patients undergoing coronary computed tomography angiography (CCTA) in an Italian tertiary referral center.

268. Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.

作者: Yuichiro Mori.;Mitsuaki Sawano.;Shun Kohsaka.;Yusuke Tsugawa.;Motoko Yanagita.;Shingo Fukuma.
来源: Circulation. 2025年152卷19期1338-1347页
Early detection of atrial fibrillation (AF) is essential for preventing ischemic stroke and other cardiovascular complications. However, the incidence and prognosis of AF in the general middle-aged population remain unclear. In Japan, annual health screenings for employees include mandatory ECGs, offering a unique opportunity to fill this evidence gap.

269. Artificial Intelligence-Led Whole Coronary Artery OCT Analysis; Validation and Identification of Drug Efficacy and Higher-Risk Plaques.

作者: Benn Jessney.;Xu Chen.;Sophie Gu.;Yuan Huang.;Martin Goddard.;Adam Brown.;Daniel Obaid.;Michael Mahmoudi.;Hector M Garcia Garcia.;Stephen P Hoole.;Lorenz Räber.;Francesco Prati.;Carola-Bibiane Schönlieb.;Michael Roberts.;Martin Bennett.
来源: Circ Cardiovasc Imaging. 2025年18卷11期e018133页
Intracoronary optical coherence tomography (OCT) can identify changes following drug/device treatment and high-risk plaques, but analysis requires expert clinician or core laboratory interpretation, while artifacts and limited sampling markedly impair reproducibility. Assistive technologies such as artificial intelligence-based analysis may therefore aid both detailed OCT interpretation and patient management. We determined if artificial intelligence-based OCT analysis (AutoOCT) can rapidly process, optimize, and analyze OCT images, and identify plaque composition changes that predict drug success/failure and high-risk plaques.

270. Mexiletine as Adjunctive Therapy in Atrial Fibrillation Following Dofetilide Treatment Failure.

作者: Carlos Ceron.;Raj Dalsania.;Farid Farkouh.;Jianzeng Dong.;Gan-Xin Yan.
来源: Circ Arrhythm Electrophysiol. 2025年18卷10期e014055页

271. Unraveling the Pathophysiological Mechanisms of Phospholamban R14del Cardiomyopathy: A Comprehensive Overview.

作者: Renee G C Maas.;Luuk Kerckhaert.;Judy Broersma.;Evangelia G Kranias.;Pieter A Doevendans.;Joost P G Sluijter.;Francesca Stillitano.
来源: Circ Heart Fail. 2025年e012661页
The discovery of the PLN-R14del (deletion of arginine 14 [p.Arg14del] within the phospholamban protein) genetic mutation, characterized by a deletion of R14 in phospholamban, in a large Greek family marked a significant milestone in understanding the cause of its associated cardiomyopathy. Since its initial identification in 2006, this mutation has been found in numerous patients across 11 countries. PLN-R14del carriers commonly exhibit both dilated cardiomyopathy and arrhythmogenic cardiomyopathy, accounting for a significant portion of annual heart transplants in the Netherlands. Under physiological conditions, PLN plays a crucial role in regulating the calcium pump SERCA2a (sarco[endo]plasmic reticulum calcium ATPase 2a) within cardiomyocytes. While the normal function of PLN has been extensively studied, the precise mechanisms underlying the pathogenesis of PLN-R14del-induced heart disease remain uncertain and subject to ongoing debate. The current review systematically summarizes existing literature on the PLN-R14del mutation, elucidating its pathological phenotypes and discussing its implications in PLN-R14del cardiomyopathy. Current knowledge is consolidated, and unresolved questions are addressed with the aim to contribute to a deeper understanding of PLN-R14del-associated cardiac pathology. Finally, this review provides guidance for future research to advance diagnosis and therapeutic approaches for affected individuals.

272. Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation.

作者: Masahiro Natsuaki.;Hirotoshi Watanabe.;Takeshi Morimoto.;Ko Yamamoto.;Yuki Obayashi.;Ryusuke Nishikawa.;Tomoya Kimura.;Kenji Ando.;Satoru Suwa.;Tsuyoshi Isawa.;Hiroyuki Takenaka.;Tetsuya Ishikawa.;Toshihiro Tamura.;Kandoh Kawahatsu.;Fujio Hayashi.;Masaharu Akao.;Takeshi Serikawa.;Hiroyoshi Mori.;Takayuki Kawamura.;Arata Hagikura.;Naoki Shibata.;Koh Ono.;Takeshi Kimura.
来源: Circ Cardiovasc Interv. 2025年18卷11期e015495页
There were no previous studies comparing aspirin with clopidogrel on top of oral anticoagulation (OAC) within 1 year after percutaneous coronary intervention when dual therapy with OAC and clopidogrel was recommended.

273. Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy.

作者: Sophie L V M Stroeks.;Marco Merlo.;Nerea Mora-Ayestaran.;Max Jason.;Upasana Tayal.;Ping Wang.;Antonio Cannatà.;Maurits A Sikking.;Matteo Dal Ferro.;Belen Peiro.;Myrthe Willemars.;Debby M E I Hellebrekers.;Rick E W van Leeuwen.;Martina Setti.;Esther Gonzalez-Lopez.;Ingrid P C Krapels.;Carola Pio Loco Detto Gava.;Arthur van den Wijngaard.;Michiel T H M Henkens.;Manuela Iseppi.;Anne G Raafs.;Martijn F Hoes.;Vanessa P M van Empel.;Elizabeth A V Jones.;Miranda Nabben.;Matthew Taylor.;Han G Brunner.;Juan Pablo Ochoa.;Fernando Dominguez.;Neal K Lakdawala.;Gianfranco Sinagra.;Pablo Garcia-Pavia.;Luisa Mestroni.;Stephane R B Heymans.;Job A J Verdonschot.
来源: Circ Heart Fail. 2025年18卷11期e012592页
Dilated cardiomyopathy (DCM) is a genetically heterogeneous disease, presenting diverse clinical phenotypes and outcomes based on the underlying gene affected. The influence of sex on the gene-specific long-term prognosis of patients with genetic DCM remains unclear. This study aims to determine the effect of sex on the long-term prognosis per underlying genogroup.

274. Intraoperative Massive Acute Ventricular Wall Thickening During HeartMate 3 Implantation.

作者: Merna Hussien.;Matthew Johnson.;Elaine Huang.;Tania A Vora.;Farooq H Sheikh.;Keki R Balsara.;Alexander I Papolos.
来源: Circ Heart Fail. 2025年e012797页

275. National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity.

作者: Manyoo A Agarwal.;Pratyakash K Srivastava.;Carolyn S P Lam.;Gregg C Fonarow.;Boback Ziaeian.
来源: Circ Heart Fail. 2025年18卷11期e013089页

276. Myocardial Entropy and Risk Predictors in Hypertrophic Cardiomyopathy: An Analysis From the NHLBI HCM Registry.

作者: Panagiotis Antiochos.;Yin Ge.;Michael Jerosch-Herold.;Louis-Philippe David.;Bobak Heydari.;Paul Kolm.;Dong-Yun Kim.;Rob J van der Geest.;Hugh Watkins.;Milind Y Desai.;Carolyn Y Ho.;Sarahfaye F Dolman.;Patrice Desvigne-Nickens.;Martin S Maron.;Jeanette Schulz-Menger.;Stefan K Piechnik.;Evan Appelbaum.;William S Weintraub.;Stefan Neubauer.;Christopher M Kramer.;Raymond Y Kwong.
来源: Circ Cardiovasc Imaging. 2025年18卷11期e018031页
Entropy, a novel measure of myocardial tissue heterogeneity by cardiovascular magnetic resonance imaging, may have clinical value in patients with hypertrophic cardiomyopathy (HCM). We aimed to investigate the associations of entropy with risk predictors in HCM, using the National Heart, Lung, and Blood Institute HCM Registry.

277. Trends in Health Care Services Use and Mortality in Adults With Cardiometabolic Diseases During the First Year of the Pandemic in Ontario, Canada.

作者: Tetyana Kendzerska.;Mouaz Saymeh.;Michael Pugliese.;Marcus Povitz.;Brandon Robinson.;Jodi D Edwards.;Teresa To.;Andrea S Gershon.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷10期e011996页
The COVID-19 pandemic disrupted health services, particularly affecting individuals with cardiometabolic diseases. This study compared health care use and mortality trends in adults with cardiometabolic diseases during the first pandemic year. It also examined associations between changes in outpatient visits and diagnostic tests with acute health care utilization and mortality.

278. PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.

作者: Jing Gan.;Ruyi Zhao.;Dong Zhen.;Yue Peng.;Maolan Wu.;Feifan Sun.;Ruike An.;Aimin Xu.;Maohua Chen.;Yulin Li.;Wei Lei.;Zhuofeng Lin.;Fan Wu.
来源: Circulation. 2025年152卷16期1146-1165页
PYGM (muscle glycogen phosphorylase), the rate-limiting enzyme in glycogenolysis, plays an indispensable role in maintaining cardiac energy metabolism. However, the role of PYGM in the pathogenesis of myocardial infarction (MI) remains unclear.

279. Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries.

作者: Amgad Mentias.;Neil Keshvani.;Milind Y Desai.;Samir R Kapadia.;Khaled M Ziada.;Cian P McCarthy.;Hurst M Hall.;Ki Park.;Dharam J Kumbhani.;A Michael Lincoff.;James L Januzzi.;Ambarish Pandey.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷10期e012136页
Type 2 myocardial infarction (MI) is common among older adults and is associated with adverse outcomes in single-center studies. We aimed to examine temporal trends and compare outcomes between type 1 and type 2 MI in Medicare beneficiaries.

280. PNPLA2 Mutation-Associated Cardiomyopathy Mimicking Dilated Cardiomyopathy: A Case Report.

作者: Keyan Wang.;Jie Zheng.;Yong Zhang.
来源: Circ Cardiovasc Imaging. 2025年e018597页
共有 62501 条符合本次的查询结果, 用时 3.3505988 秒